June 14 (Reuters) - Avalon Globocare Corp AVCO.O :
* AVALON GLOBOCARE ANNOUNCES EXECUTION OF PURCHASE AGREEMENT
FOR
ACQUISITION OF SENLANGBIO IN ALL STOCK TRANSACTION
* AVALON GLOBOCARE CORP - AVALON TO SELL 15.6% EQUITY
INTEREST IN
SENLANGBIO TO INSTITUTIONAL HEALTHCARE INVESTOR FOR USD $30
MILLION
* AVALON GLOBOCARE - CO TO ACQUIRE SENLANGBIO'S PROPRIETARY
CELLULAR THERAPY PORTFOLIO CONSISTING OF MULTIPLE AUTOLOGOUS &
ALLOGENEIC CANDIDATES
* AVALON GLOBOCARE CORP - CO WILL ISSUE 81 MILLION SHARES OF
ITS
COMMON STOCK TO ACQUIRE SENLANGBIO
Source text for Eikon: ID:nGNX4HNbGG
Further company coverage: AVCO.O
((Reuters.Briefs@thomsonreuters.com;))